ELF4/TRIB3/CDK6轴促进癌症干细胞活动在子宫内膜癌
Chun-Yu Chen1,2, Yueh-Chun Lee3,4, Yu-Hao Huang5
1Department of Emergency Medicine, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan.
Journal of cellular physiology
|November 25, 2025
概括
较高的E74类ETS转录因子4 (ELF4) 通过调节循环素依赖激酶6 (CDK6) 来驱动子宫内膜癌 (EC) 的进展. 针对ELF4/TRIB3/CDK6轴可能提供新的子宫内膜癌疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 子宫内膜癌 (EC) 是全球领先的妇科恶性瘤.
- 了解EC进展的分子驱动因素对于开发向疗法至关重要.
研究的目的:
- 调查类似于E74的ETS转录因子4 (ELF4) 在子宫内膜癌 (EC) 进展中的作用.
- 确定EC的ELF4下游目标和监管途径.
主要方法:
- 使用TISIDB网络工具进行TCGA数据分析.
- 对EC标本进行组织微阵列分析.
- 使用EC细胞系和患者衍生的细胞进行体外研究,涉及基因敲除和过度表达.
- 染色体免疫沉测定. 染色体免疫沉测定.
- 对茎状标志物和瘤球形成的分析.
主要成果:
- 较高的ELF4表达与较高的EC等级和较差的生存率相关.
- 抑制ELF4抑制了EC细胞的增殖,细胞循环和癌症干细胞 (CSC) 的活性.
- ELF4直接准并调节循环林依赖性激酶6 (CDK6) 的表达.
- 该ELF4/TRIB3复合体协同调节CDK6.
- ELF4,TRIB3和CDK6的共同表达预测了EC的不良预后.
结论:
- ELF4/TRIB3/CDK6信号轴是EC进展和CSC维护的关键调节器.
- 这个轴代表了子宫内膜癌的潜在治疗标.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Renewal of Intestinal Stem Cells
3.1K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
3.1K


